deltatrials
Terminated OBSERVATIONAL NCT02612376

Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study

Sponsor: University of Colorado, Denver

Updated 17 times since 2017 Last updated: May 28, 2025 Started: Feb 29, 2016 Primary completion: Apr 30, 2025 Completion: May 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Loss of funding

This observational or N/A phase trial investigates Alzheimer Disease and Down Syndrome and is currently terminated or withdrawn. University of Colorado, Denver leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Feb 2020 · 13 months · monthly snapshot~Feb 2020 – ~Nov 2020 · 9 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Feb 2024 · 26 months · monthly snapshot~Feb 2024 – ~May 2024 · 3 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – present · 12 months · monthly snapshot

Change History

17 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated

    Status: RecruitingTerminated

  2. Sep 2024 — Jun 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. May 2024 — Jul 2024 [monthly]

    Recruiting

    Status: Unknown StatusRecruiting

  5. Feb 2024 — May 2024 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

Show 12 earlier versions
  1. Dec 2021 — Feb 2024 [monthly]

    Recruiting

  2. Sep 2021 — Dec 2021 [monthly]

    Recruiting

  3. May 2021 — Sep 2021 [monthly]

    Recruiting

  4. Jan 2021 — May 2021 [monthly]

    Recruiting

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  6. Feb 2020 — Nov 2020 [monthly]

    Recruiting

  7. Jan 2019 — Feb 2020 [monthly]

    Recruiting

  8. Jun 2018 — Jan 2019 [monthly]

    Recruiting

  9. May 2018 — Jun 2018 [monthly]

    Recruiting

  10. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  11. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  12. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Colorado, Denver
Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations